Center Laboratories (4123) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 晟德

Center Laboratories (4123) reported revenue of NT$142.9 million for Oct 2026, +6.1% year on year and -17.7% from the previous month. Revenue for Jan–Oct 2026 was NT$1.52 billion (+21.6% year on year).

Year-on-year revenue growth: 8 months in a row. →

In Oct 2026, it ranked No. 58 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$196.7 million24/10Nov 2024 NT$132.7 millionDec 2024 NT$120.6 millionJan 2025 NT$122.3 millionFeb 2025 NT$160.7 million25/02Mar 2025 NT$95.1 millionApr 2025 NT$138.2 millionMay 2025 NT$128.1 millionJun 2025 NT$113 million25/06Jul 2025 NT$135.8 millionAug 2025 NT$93.5 millionSep 2025 NT$130.2 millionOct 2025 NT$134.7 million25/10Nov 2025 NT$114.9 millionDec 2025 NT$149.9 millionJan 2026 NT$191.3 millionFeb 2026 NT$126.8 million26/02Mar 2026 NT$147.9 millionApr 2026 NT$177.3 millionMay 2026 NT$138.5 millionJun 2026 NT$116.3 million26/06Jul 2026 NT$156.5 millionAug 2026 NT$151 millionSep 2026 NT$173.5 millionOct 2026 NT$142.9 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$142.9 million+6.1%-17.7%
Sep 2026NT$173.5 million+33.3%+15.0%
Aug 2026NT$151 million+61.5%-3.6%
Jul 2026NT$156.5 million+15.3%+34.6%
Jun 2026NT$116.3 million+2.9%-16.0%
May 2026NT$138.5 million+8.1%-21.9%
Apr 2026NT$177.3 million+28.3%+19.9%
Mar 2026NT$147.9 million+55.6%+16.6%
Feb 2026NT$126.8 million-21.1%-33.7%
Jan 2026NT$191.3 million+56.4%+27.6%
Dec 2025NT$149.9 million+24.4%+30.5%
Nov 2025NT$114.9 million-13.4%-14.7%
Oct 2025NT$134.7 million-31.5%+3.5%
Sep 2025NT$130.2 million+23.5%+39.3%
Aug 2025NT$93.5 million-36.7%-31.2%
Jul 2025NT$135.8 million-3.3%+20.2%
Jun 2025NT$113 million-6.2%-11.8%
May 2025NT$128.1 million-15.1%-7.3%
Apr 2025NT$138.2 million-2.1%+45.3%
Mar 2025NT$95.1 million-18.6%-40.8%
Feb 2025NT$160.7 million+70.9%+31.4%
Jan 2025NT$122.3 million-19.8%+1.4%
Dec 2024NT$120.6 million-16.9%-9.1%
Nov 2024NT$132.7 million+4.7%-32.5%
Oct 2024NT$196.7 million+47.2%+86.6%

Jan–Oct 2026 cumulative: NT$1.52 billion (+21.6% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Center Laboratories vs PEC / Center Laboratories vs Lotus Pharm / Center Laboratories vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16